LUPIN - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

Technical Rating: 4.2

Technical Analysis Summary

• Trend: Consolidating near key moving averages
• Moving Averages: Price (₹1,969) is hovering around DMA 50 (₹1,953) and DMA 200 (₹1,968), indicating indecision
• RSI (53.4): Neutral zone, no overbought/oversold signal
• MACD (-4.53): Bearish crossover, suggesting short-term weakness
• Bollinger Bands: Price is near mid-band, indicating low volatility and consolidation
• Volume: Above average (10.33L vs 7.62L), hinting at accumulation

Entry & Exit Zones

• Support: ₹1,920 – ₹1,950 (near DMA levels)
• Resistance: ₹2,100 – ₹2,150 (recent swing highs)
• Optimal Entry: ₹1,930 – ₹1,950 on pullback with volume confirmation
• Exit Zone: ₹2,100 – ₹2,150 if momentum fades near resistance

Positive

• Strong quarterly PAT growth of 139%
• Low debt-to-equity ratio (0.01) and high ROCE (21.9%)
• PEG ratio of 0.10 indicates undervaluation relative to growth
• EPS of ₹114 and P/E of 17.1 vs industry P/E of 33.1

Limitation

• MACD bearish crossover could limit short-term upside
• FII holding declined by 0.75%
• RSI and Bollinger Bands suggest lack of strong momentum

Company Negative News

• No major negative news reported recently

Company Positive News

• Strong quarterly earnings beat expectations
• Positive sentiment from domestic institutional investors (DII holding up by 1.01%)

Industry

• Pharmaceuticals sector remains resilient with high demand for generics
• Lupin competes with peers like Dr. Reddy’s, Zydus, and Alkem Labs

Conclusion

Lupin is currently consolidating near key moving averages with neutral momentum indicators. While short-term signals are mixed, strong fundamentals and valuation support a bullish medium-term outlook. Traders may consider accumulating near support zones with a target around ₹2,150–₹2,326.

Let me know if you'd like this formatted for a dashboard or embedded in a report.